European Market Report for Flash Glucose Monitoring 2016 - MedCore

  • ID: 3846022
  • Report
  • Region: Europe
  • 64 pages
  • iData Research
1 of 5

FEATURED COMPANIES

  • Abbott
  • Ascensia
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Menarini
  • MORE
The European FGM market comprises the FGM reader segment and the FGM sensor segment. The business model for FGM is similar to traditional blood glucose meters and CGM, where the reader is the base equipment and the majority of sales are made from the disposable sensor component, which is replaced every 14 days.

However, due to a recent product update that allows patients to use near-field communication (NFC) technology to substitute their smartphones as the reader component, purchase of the reader device is no longer mandatory. As a result, the disposable sensors will be the most important revenue generator for the FGM market as it gains further acceptance and higher uptake in Europe.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Ascensia
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Menarini
  • MORE
Table Of Contents I
List Of Figures Iv
List Of Charts V
Executive Summary
European Market For Diabetes Monitoring, Treatment And Drug Delivery
Competitive Analysis
Market Trends
Market Developments
Markets Included
Key Report Updates
Version History
Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
Disease Overview
2.1 Introduction
2.1.1 Types Of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated With Type 1 And Type 2 Diabetes
2.1.4 Signs And Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems
Country Profiles
3.1 Introduction
3.1.1 Population
3.1.2 Gdp Per Capita
3.1.3 Units
3.2 Germany
3.3 France
3.4 United Kingdom
3.5 Italy
3.6 Spain
3.7 Benelux
3.8 Scandinavia
3.9 Austria
3.10 Switzerland
3.11 Portugal
Flash Glucose Monitoring Market
4.1 Introduction
4.2 Market Overview
4.3 Market Analysis And Forecast
4.3.1 Total Fgm Market
4.3.2 Fgm System Market
4.3.3 Fgm Sensor Market
4.4 Drivers And Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis
Abbreviations

Chart 1 1: Diabetes Diagnosis, Treatment and Drug Delivery, Europe, 2012 – 2022
Chart 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Market Overview, Europe, 2012 & 2022
Chart 3 1: Country Profile, Germany, 2015
Chart 3 2: Country Profile, France, 2015
Chart 3 3: Country Profile, United Kingdom, 2015
Chart 3 4: Country Profile, Italy, 2015
Chart 3 5: Country Profile, Spain, 2015
Chart 3 6: Country Profile, Benelux, 2015
Chart 3 7: Country Profile, Scandinavia, 2015
Chart 3 8: Country Profile, Austria, 2015
Chart 3 9: Country Profile, Switzerland, 2015
Chart 3 10: Country Profile, Portugal, 2015
Chart 4 1: Total FGM Market by Segment, Europe, 2015
Chart 4 2: Total FGM Market Breakdown, Europe, 2022
Chart 4 3: Total FGM Market Breakdown, Europe, 2022
Chart 4 4: Total FGM Market, Europe, 2012 – 2022 (€M)
Chart 4 5: FGM System Market, Europe, 2012 – 2022
Chart 4 6: FGM Sensor Market, Europe, 2012 – 2022
Chart 4 7: Leading Competitors, FGM Market, Europe, 2015

Figure 1 1: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 2)
Figure 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 2)
Figure 1 3: Companies Researched in this Report, Europe, 2015
Figure 1 4: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (1 of 2)
Figure 1 5: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (2 of 2)
Figure 1 6: Recent Events in the Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2012 – 2016
Figure 2 1: Major Types of Diabetes and Related Pathologies, Europe, 2015
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, Europe, 2015
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, Europe, 2015
Figure 4 1: Total FGM Market by Segment, Europe, 2012 – 2022 (€M)
Figure 4 2: Total FGM Market by Segment, Europe, 2012 – 2022 (US$M)
Figure 4 3: Total FGM Market, Europe, 2012 – 2022 (€ and US$)
Figure 4 4: FGM System Market, Europe, 2012 – 2022 (€ and US$)
Figure 4 5: FGM Sensor Market, Europe, 2012 – 2022 (€ and US$)
Figure 4 6: Drivers and Limiters, FGM Market, Europe, 2015
Figure 4 7: Leading Competitors, FGM Market, Europe, 2015
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Ascensia
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Menarini
  • MORE
The FGM system is made up of two components: a sensor and an electronic reader device that takes readings of glucose levels from the sensor. Sensors are worn on the back of the upper arm of patients for up to 14 days and inserted in a similar fashion as CGM sensors, with an adhesive to hold it in place. The reader component is manually placed over the sensor and after about a second, the reader displays a measurement of the patient’s glucose level, a historical trend of previous scans and the direction in which the glucose level is moving.

A recent product update allows patients to use near-field communication (NFC) technology to substitute their smartphones as the reader component, eliminating the need to purchase the dedicated reader device. The FGM system is also factory calibrated which removes the need for routine fingersticks; something that is not available in current CGM systems. These features are popular with patients who cite “the pain, inconvenience and indiscretion” of fingersticking as the primary reasons for not managing their diabetes as efficiently and proactively as they should.
Note: Product cover images may vary from those shown
5 of 5
Novo Nordisk
Sanofi
Roche
Johnson & Johnson
Eli Lilly
Abbott
Ascensia
Becton Dickinson
Medtronic
Menarini
DexCom
Ypsomed
Insulet
Artsana
B. Braun
Terumo
Others include: Abbott, AgaMatrix, Artsana, Apollo, BBI Healthcare, B. Braun, Berger, Beurer, Boehringer Ingelheim, Cellnovo, Codan, Comfort Point, Dario Health, Elektronika, Entra Health Systems, GlucoRx, GlucoZen, Infopia, Medtronic, MED TRUST, Medisana, Menarini, Merck Serono, MSP bodmann, Neon Diagnostics, NordicInfu Care, Novalab Ibérica, Novico, Owen Mumford, Pentaferte, Roche, Sanofi, SD BIOSENSOR, SFM Medical, Smiths Medical, Spirit Healthcare, Sooil, Trividia Health, Ypsomed, etc.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll